Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Following the design path of isoform-selective Hsp90 inhibitors: Small differences, great opportunities
Jaka Dernovšek, Tihomir Tomašič
Pharmacology & Therapeutics (2023) Vol. 245, pp. 108396-108396
Open Access | Times Cited: 23

Showing 23 citing articles:

Advances in the structures, mechanisms and targeting of molecular chaperones
Jinying Gu, Yanyi He, Chenxi He, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Recent developments of HSP90 inhibitors: an updated patent review (2020-present)
Liu Jian-feng, Huangliang Shu, Qinxin Xia, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 1-2, pp. 1-15
Closed Access | Times Cited: 6
Comprehensive analysis of resorcinyl-imidazole Hsp90 inhibitor design
Marius Gedgaudas, Paulina Kaziukonytė, Visvaldas Kairys, et al.
European Journal of Medicinal Chemistry (2024) Vol. 273, pp. 116505-116505
Closed Access | Times Cited: 6
Exploration and optimisation of structure-activity relationships of new triazole-based C-terminal Hsp90 inhibitors towards in vivo anticancer potency
Jaka Dernovšek, Živa Zajec, Goran Poje, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116941-116941
Open Access | Times Cited: 6
Microplastic exposure induces HSP90α secretion and aggravates asthmatic airway remodeling via PI3K-Akt-mTOR pathway
Mingming Xu, Jiyuan Chen, Lin Gao, et al.
Ecotoxicology and Environmental Safety (2025) Vol. 291, pp. 117828-117828
Open Access
Mechanisms and applications of mitochondrial chaperone inhibitors
Gianna Mochi, Mark R. Woodford
Transactions of the Royal Society of South Africa (2025), pp. 1-10
Closed Access
Geldanamycin, a Naturally Occurring Inhibitor of Hsp90 and a Lead Compound for Medicinal Chemistry
Russell R. A. Kitson, Dominika Kitsonová, David Siegel, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 20, pp. 17946-17963
Open Access | Times Cited: 4
AHSA1-HSP90AA1 complex stabilized IFI6 and TGFB1 promotes mitochondrial stability and EMT in EGFR-mutated lung adenocarcinoma under Osimertinib pressure
Ying Sui, Ziyang Shen, Rongtian Pan, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Discovery of new Hsp90–Cdc37 protein–protein interaction inhibitors: in silico screening and optimization of anticancer activity
Jaka Dernovšek, Nina Gradišek, Živa Zajec, et al.
RSC Advances (2024) Vol. 14, Iss. 39, pp. 28347-28375
Open Access | Times Cited: 3
Rational Design of Peptide Inhibitors Targeting HSP90–CDC37 Protein–Protein Interaction
Qiuyue Zhang, Ling Yan, Yuxuan Zhang, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 2, pp. 125-138
Open Access | Times Cited: 2
The components of the AhR‐molecular chaperone complex differ depending on whether the ligands are toxic or non‐toxic
Yukihiko Narita, Arisa Tamura, Shiori Hatakeyama, et al.
FEBS Letters (2024) Vol. 598, Iss. 12, pp. 1478-1490
Open Access | Times Cited: 2
Hsp90α and cell death in cancers: a review
Bin Liu, Daohai Qian
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Structural Characterization of Heat Shock Protein 90β and Molecular Interactions with Geldanamycin and Ritonavir: A Computational Study
Carlyle Ribeiro Lima, Deborah Antunes, Ernesto R. Caffarena, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8782-8782
Open Access | Times Cited: 2
Hiding in plain sight: Optimizing topoisomerase IIα inhibitors into Hsp90β selective binders
Jaka Dernovšek, Tjaša Goričan, Marius Gedgaudas, et al.
European Journal of Medicinal Chemistry (2024) Vol. 280, pp. 116934-116934
Open Access | Times Cited: 2
Targeting HSP90 with picropodophyllin suppresses gastric cancer tumorigenesis by disrupting the association of HSP90 and AKT
Xiaoli Li, Guoli Wang, Xiaolin Zhou, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 10, pp. 4740-4754
Closed Access | Times Cited: 5
The development of cancers research based on mitochondrial heat shock protein 90
Yuchu Xiang, Xudong Liu, Qi Sun, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 5
First dual inhibitors of human topoisomerase IIα and Hsp90 C-terminal domain inhibit the growth of Ewing sarcoma in vitro and in vivo
Jaka Dernovšek, Dunja Urbančič, Živa Zajec, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107850-107850
Open Access | Times Cited: 1
Design, synthesis and biological studies of new isoxazole compounds as potent Hsp90 inhibitors
Fariba Keshavarzipour, Maryam Abbasi, Zahra Khorsandi, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Natural and Synthetic Inhibitors of Heat Shock Protein 90 Chaperone in Cancer Treatment
Shravanthi Ravula, Sravani Akula, Rama Krishna Kancha
Indian Journal of Pharmaceutical Education and Research (2024) Vol. 58, Iss. 2, pp. 401-410
Open Access
Design, synthesis and biological evaluation of new isoxazole derivatives as Hsp90 inhibitors
Fariba Keshavarzipour, Maryam Abbasi, Zahra Khorsandi, et al.
Research Square (Research Square) (2024)
Open Access
Heat shock protein 90α reduces CD8+ T cell exhaustion in acute lung injury induced by lipopolysaccharide
Lei Yan, Yumei Chen, Yilin Yang, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access
The Roles of Two Isoforms of Heat Shock Protein Hsp90 in the Resistance of Human Fibrosarcoma HT1080 Cells to Hsp90 Inhibitors and Cytoxic Drugs
V. S. Petrenko, O. S. Morenkov, Y. Y. Skarga, et al.
BIOPHYSICS (2024) Vol. 69, Iss. 6, pp. 1045-1053
Closed Access
The Role of Two Isoforms of Heat Shock Protein Hsp90 in Resistance of Human Fibrosarcoma Cells HT1080 to Hsp90 Inhibitors and Cytoxic Drugs
V. S. Petrenko, O. S. Morenkov, Y. Y. Skarga, et al.
Биофизика (2024) Vol. 69, Iss. 6, pp. 1214-1223
Closed Access
Insights into the Allosteric Regulation of Human Hsp90 Revealed by NMR Spectroscopy
Tjaša Goričan, Simona Golič Grdadolnik
Biomolecules (2024) Vol. 15, Iss. 1, pp. 37-37
Open Access
Page 1

Scroll to top